Pharmaceutical Affairs Act Article 48-21

Before the enforcement of the provisions amended on December 29, 2017, the new drug license holders whose drug patent(s) is subject to the drug patent as stipulated in Paragraph 2, Article 48-3 and has not extinguished yet may submit patent information in accordance with Article 48-4 within 3 months after the enforcement of the amended provisions.